BlueCrest Capital Management’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History

BlueCrest Capital Management’s Portfolio SLXP Stock Details SLXP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	–	Sell	-20,000	Closed	-$3.13M	–	750
2014 Q3	$3.13M	Buy	+20,000	New	+$2.9M	0.12%	173

Other funds holding SLXP

MMG

Monetary Management Group St Louis, Missouri $419M AUM 29.55% 1-Year Est. Return

BlueCrest Capital Management's SLXP Position: Q2 2015 in Review

BlueCrest Capital Management sold out of SALIX PHARMACEUTICALS LTD DEL (SLXP) in Q2 2015, closing a stake of 63,231 shares — an estimated $10.9M sold.

BlueCrest Capital Management first reported a position in SLXP in Q3 2014 and held it in 2 quarters. The position peaked at $10.9M in Q1 2015. 1 fund tracked by Wall St. Rank holds SLXP as of Q2 2015.

BlueCrest Capital Management reported no remaining SALIX PHARMACEUTICALS LTD DEL position as of Q2 2015 after selling out during the quarter.
BlueCrest Capital Management sold 63,231 SALIX PHARMACEUTICALS LTD DEL shares in Q2 2015, an estimated $10.9M.
BlueCrest Capital Management first reported a position in SALIX PHARMACEUTICALS LTD DEL in Q3 2014 and held it in 2 quarters.
BlueCrest Capital Management's SALIX PHARMACEUTICALS LTD DEL position peaked at $10.9M in Q1 2015.
1 fund tracked by Wall St. Rank held SALIX PHARMACEUTICALS LTD DEL as of Q2 2015.

Based on BlueCrest Capital Management's 13F filing for Q2 2015, filed 14 Aug 2015.